IE
MEDP icon

Israel Englander’s Medpace MEDP Stock Holding History

Israel Englander’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,000
Closed -$1.92M – 6194
2026
Q1 		$1.92M Buy
+4,000
New +$2.05M ﹤0.01% 3910
2025
Q4 		– Sell
-400
Closed -$206K – 6282
2025
Q3 		$206K Buy
+400
New +$175K ﹤0.01% 5534
2024
Q4 		– Sell
-23,100
Closed -$7.71M – 6242
2024
Q3 		$7.71M Buy
+23,100
New +$8.78M ﹤0.01% 2432
2024
Q2 		– Sell
-23,500
Closed -$9.5M – 6284
2024
Q1 		$9.5M Buy
+23,500
New +$8.26M ﹤0.01% 2240
2019
Q3 		– Sell
-50,000
Closed -$3.27M – 4399
2019
Q2 		$3.27M Buy
+50,000
New +$2.88M ﹤0.01% 2100

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Israel Englander's MEDP Position: Q2 2026 in Review

Israel Englander sold out of Medpace (MEDP) in Q2 2026, closing a stake of 5,676 shares — an estimated $2.62M sold.

Israel Englander first reported a position in MEDP in Q3 2016 and held it in 34 quarters. The position peaked at $108M in Q2 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Israel Englander reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 5,676 Medpace shares in Q2 2026, an estimated $2.62M.
  • Israel Englander first reported a position in Medpace in Q3 2016 and held it in 34 quarters.
  • Israel Englander's Medpace position peaked at $108M in Q2 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.